세포은행 아웃소싱 시장 - 세계 산업 규모, 점유율, 동향, 기회, 예측(2017-2027년), 유형별, 세포 유형별, 단계별, 기업별, 지역별 분석
Cell Banking Outsourcing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Type, By Cell Type, By Phase, By Company, and By Region
세계 세포은행 아웃소싱 시장은 2023-2027년 예측 기간 동안 괄목할 만한 성장을 이룰 것으로 예상됩니다.
주요 요인으로는 만성 질환의 증가, 부모 세대의 인식 증가, 노인 인구의 증가 등이 시장 성장을 촉진하는 요인으로 작용하고 있습니다. 세포은행 아웃소싱은 미래의 목적을 위해 특정 게놈의 세포를 저장하는 능력입니다. 세포은행 아웃소싱은 세포주의 완전한 특성화를 위해 사용할 수 있으며, 세포주의 교차 오염을 줄이는 데 도움이 될 수 있습니다. 기타 시장 성장 요인으로는 R&D 활동에 대한 대규모 투자, 임상 시험 수 증가, 줄기세포 치료 및 유전자 치료에 대한 수요 증가, 줄기세포 응용에 대한 연구 활동 증가, 생물학적 제제에 대한 수요 증가, 첨단 보존 기술 개발, 임상 시험 수 증가, 의료 산업 확대 등이 있습니다. 등이 있습니다. 또한, 시장 관계자들의 제휴 및 인수 전략 채택이 증가하고 있는 것도 시장 성장을 촉진하고 있습니다.
만성질환의 만연과 노령인구 증가
당뇨병, 심혈관 질환과 같은 만성 질환의 증가는 전 세계적으로 시장 성장을 강화하고 있으며, WHO에 따르면 심혈관 질환(CVD)은 전 세계 주요 사망 원인으로 매년 약 1억 7,900만 명의 목숨을 앗아갑니다. 이러한 질병은 부작용으로 인해 기존의 방법으로 치료할 수 없기 때문에 줄기세포는 다양한 만성질환 치료에 사용되고 있습니다. 따라서 줄기세포를 치료에 사용함으로써 치료로 인한 위험과 손상을 줄일 수 있습니다. 이러한 치명적인 질병을 앓고 있는 사람들의 수가 계속 증가함에 따라 줄기세포 치료 및 유전자 치료에 대한 수요가 증가하고 있으며, 이는 시장 성장을 촉진하고 있습니다.
노령인구 증가가 시장을 지탱하는 요인으로 작용
세계 노인 인구의 증가는 줄기세포 치료의 수요를 증가시켜 시장 성장을 촉진하고 있습니다. 세계보건기구(WHO) 데이터에 따르면, 60세 이상 인구가 전체 인구에서 차지하는 노인 인구의 수와 비율이 증가하고 있으며, 2019년 60세 이상 노인 인구는 10억 명에 달했습니다. 이 숫자는 2030년에는 14억 명, 2050년에는 21억 명으로 증가할 것으로 예상됩니다.
줄기세포은행에 대한 인식 제고
다양한 신흥국에서 줄기세포은행에 대한 인식이 높아지면서 시장 성장에 힘을 실어주고 있습니다. 현재 사람들은 미래의 목적을 위해 줄기세포은행을 이용하는 것의 이점에 대해 더 많이 인식하고 있습니다. 건강 전문가들이 줄기세포 보존의 중요성과 이점에 대해 교육하기 시작하면서 부모와 임산부들의 인식이 높아졌고, 이는 세계 시장 성장을 견인하고 있습니다. 예를 들어, 미국에서는 900만 명 이상의 기증자 등록이 이루어지고 있습니다. 또한 기증자 등록에는 266,000개의 제대혈 유닛이 포함되어 있으며, 그 중 115,000개는 National Cord Blood Inventory(NCBI)의 것이며, 2021년에는 4,000개 이상의 NCBI 유닛이 추가될 예정입니다.
이용 가능한 커스터마이징
주어진 시장 데이터를 바탕으로 TechSci Research는 기업의 특정 요구에 따라 맞춤형을 제공합니다. 본 보고서는 다음과 같은 커스터마이징이 가능합니다.
기업 정보
- 추가 시장 참여자(최대 5개사)에 대한 상세한 분석 및 프로파일링
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 세계의 세포은행 아웃소싱 시장에 대한 COVID-19의 영향
제5장 고객의 소리
제6장 세계의 세포은행 아웃소싱 시장 전망
- 시장 규모와 예측
- 시장 점유율과 예측
- 유형별(마스터 세포은행, 워킹 세포은행, 바이러스 세포은행)
- 세포 유형별(줄기세포, 비줄기세포)
- 단계별(은행 보관, 은행 특성 평가·시험, 은행 준비)
- 기업별(2021년)
- 지역별
- 시장 맵
제7장 북미의 세포은행 아웃소싱 시장 전망
- 시장 규모와 예측
- 시장 점유율과 예측
- 북미 : 국가별 분석
제8장 유럽의 세포은행 아웃소싱 시장 전망
- 시장 규모와 예측
- 시장 점유율과 예측
- 유럽 국가별 분석
제9장 아시아태평양의 세포은행 아웃소싱 시장 전망
- 시장 규모와 예측
- 시장 점유율과 예측
- 아시아태평양의 국가별 분석
제10장 남미의 세포은행 아웃소싱 시장 전망
- 시장 규모와 예측
- 시장 점유율과 예측
- 남미의 국가별 분석
제11장 중동 및 아프리카의 세포은행 아웃소싱 시장 전망
- 시장 규모와 예측
- 시장 점유율과 예측
- MEA : 국가별 분석
- 남아프리카공화국
- 사우디아라비아
- UAE
- 터키
- 이집트
제12장 시장 역학
제13장 시장 동향과 발전
제14장 경쟁 상황
- Cryo-Cell International, Inc
- Charles River Laboratories International, Inc.
- Goodwin Biotechnology Inc.
- Lonza Group AG
- SGS Life Sciences(SGS SA)
- Global Stem Inc.
- BSL Bioservice Scientific Laboratories GmbH
- BioReliance Corporation
제15장 전략적 추천사항
ksm
The global cell banking outsourcing market is anticipated to observe impressive growth during the forecast period 2023-2027. The major factors include the increase in chronic diseases, rising awareness among the parental population, and the rise in the geriatric population, which are propelling the growth of the market. Cell banking outsourcing is an ability that stores cells of a particular genome for future purposes. Cell banking outsourcing can be used to produce complete characterizations of cell lines and can also help to reduce the cross-contamination of a cell line. The other factors supporting the market's growth are extensive investments in research and development (R&D) activities, expanding the number of clinical trials, rising demand for stem cell therapies and gene therapies, rise in research activities related to stem cell applications, increasing demand for biologic products, development of advanced preservation techniques, a large number of clinical trials, and expansion of healthcare industry are bolstering the growth of the market. Also, the growing adoption of collaboration and acquisition strategies by the market players is supporting the growth of the market.
Rising Prevalence of Chronic Diseases and Increasing Geriatric Population
The increasing occurrence of chronic diseases, such as diabetes, cardiovascular diseases, and others, across the globe is strengthening the growth of the market. According to the WHO, Cardiovascular diseases (CVDs) are the leading cause of death worldwide, taking approximately 17.9 million lives each year. Stem cells are used to treat various chronic diseases as these diseases cannot be treated with traditional methods due to their adverse effect. Therefore, the use of stem cell therapy for the treatment act as a healing agent, which helps to reduce the risk or damage caused by the treatment. Owing to the continuous rise in the number of people suffering from these fatal diseases, the demand for stem cell therapies and gene therapies is rising, which is driving the growth of the market.
Increasing Geriatric Population Supports the Market
The rise in the geriatric population base across the world is surging the demand for stem cell therapy, which is impelling the growth of the market. According to the World Health Organization (WHO) data, the number and proportion of the elderly population, meaning people with age 60 years and above in the population is increasing. In 2019, the number of people aged 60 years and above was 1 billion. This number is likely to rise to 1.4 billion by 2030 and 2.1 billion by 2050.
Growing Awareness About Stem Cell Banking
Growing awareness about stem cell banking across various emerging countries is augmenting the growth of the market. Nowadays, people are becoming more aware of the benefits of stem cell banking for future purposes. Parental as well as expectant populations are becoming more aware as health specialists are starting to educate them about the significance and advantages of storing stem cells which are fueling the growth of the market globally. For instance, in the United States, the donor registry contains above 9 million potential donors. In addition, the donor registry includes 266,000 cord blood units, of which 115,000 units are from the National Cord Blood Inventory (NCBI), with over 4000 NCBI units added in 2021.
Market Segmentation
The global cell banking outsourcing market is segmented into type, cell type, Phase, and company. Based on type, the market is divided into master cell banking, working cell banking, and viral cell banking. Based on cell type, the market is divided into stem cells and non-stem cells. Based on Phase, the market is divided into bank storage, bank characterization & testing, and bank preparation. In terms of country, the United States is expected to be a lucrative market in the forecast period due to the growing prevalence of chronic and genetic disorders in the country.
Market Players
Cryo-Cell International, Inc, Charles River Laboratories International, Inc., Goodwin Biotechnology Inc., Lonza Group AG, SGS Life Sciences (SGS SA), Global Stem Inc., BSL Bioservice Scientific Laboratories GmbH, and BioReliance Corporation are some of the leading companies operating in the market.
Report Scope
In this report, global cell banking outsourcing market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:
Cell Banking Outsourcing Market, By type:
- Master Cell Banking
- Working Cell Banking
- Viral Cell Banking
Cell Banking Outsourcing Market, By Cell Type:
Cord Blood Banking, By Phase:
- Bank Storage
- Bank Characterization & Testing
- Bank Preparation
Cell Banking Outsourcing Market, By Region:
- North America
- United States
- Canada
- Mexico
- Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
- Europe & CIS
- Germany
- France
- United Kingdom
- Spain
- Italy
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Turkey
- Egypt
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Cell Banking Outsourcing Market
Available Customizations
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
2. Research Methodology
3. Executive Summary
4. Impact of COVID-19 on Global Cell Banking Outsourcing Market
5. Voice of Customer
6. Global Cell Banking Outsourcing Market Outlook
- 6.1. Market Size & Forecast
- 6.2. Market Share & Forecast
- 6.2.1. By Type (Master Cell Banking, Working Cell Banking, Viral Cell Banking)
- 6.2.2. By Cell Type (Stem Cell v/s Non-Stem Cell)
- 6.2.3. By Phase (Bank Storage, Bank Characterization & Testing, Bank Preparation)
- 6.2.4. By Company (2021)
- 6.2.5. By Region
- 6.3. Market Map
7. North America Cell Banking Outsourcing Market Outlook
- 7.1. Market Size & Forecast
- 7.2. Market Share & Forecast
- 7.2.1. By Type
- 7.2.2. By Cell Type
- 7.2.3. By Phase
- 7.2.4. By Country
- 7.3. North America: Country Analysis
- 7.3.1. United States Cell Banking Outsourcing Market Outlook
- 7.3.1.1. Market Size & Forecast
- 7.3.1.2. Market Share & Forecast
- 7.3.1.2.1. By Type
- 7.3.1.2.2. By Cell Type
- 7.3.1.2.3. By Phase
- 7.3.2. Canada Cell Banking Outsourcing Market Outlook
- 7.3.2.1. Market Size & Forecast
- 7.3.2.2. Market Share & Forecast
- 7.3.2.2.1. By Type
- 7.3.2.2.2. By Cell Type
- 7.3.2.2.3. By Phase
- 7.3.3. Mexico Cell Banking Outsourcing Market Outlook
- 7.3.3.1. Market Size & Forecast
- 7.3.3.2. Market Share & Forecast
- 7.3.3.2.1. By Type
- 7.3.3.2.2. By Cell Type
- 7.3.3.2.3. By Phase
8. Europe Cell Banking Outsourcing Market Outlook
- 8.1. Market Size & Forecast
- 8.2. Market Share & Forecast
- 8.2.1. By Type
- 8.2.2. By Cell Type
- 8.2.3. By Phase
- 8.2.4. By Country
- 8.3. Europe: Country Analysis
- 8.3.1. France Cell Banking Outsourcing Market Outlook
- 8.3.1.1. Market Size & Forecast
- 8.3.1.2. Market Share & Forecast
- 8.3.1.2.1. By Type
- 8.3.1.2.2. By Cell Type
- 8.3.1.2.3. By Phase
- 8.3.2. Germany Cell Banking Outsourcing Market Outlook
- 8.3.2.1. Market Size & Forecast
- 8.3.2.2. Market Share & Forecast
- 8.3.2.2.1. By Type
- 8.3.2.2.2. By Cell Type
- 8.3.2.2.3. By Phase
- 8.3.3. United Kingdom Cell Banking Outsourcing Market Outlook
- 8.3.3.1. Market Size & Forecast
- 8.3.3.2. Market Share & Forecast
- 8.3.3.2.1. By Type
- 8.3.3.2.2. By Cell Type
- 8.3.3.2.3. By Phase
- 8.3.4. Italy Cell Banking Outsourcing Market Outlook
- 8.3.4.1. Market Size & Forecast
- 8.3.4.2. Market Share & Forecast
- 8.3.4.2.1. By Type
- 8.3.4.2.2. By Cell Type
- 8.3.4.2.3. By Phase
- 8.3.5. Spain Cell Banking Outsourcing Market Outlook
- 8.3.5.1. Market Size & Forecast
- 8.3.5.2. Market Share & Forecast
- 8.3.5.2.1. By Type
- 8.3.5.2.2. By Cell Type
- 8.3.5.2.3. By Phase
9. Asia-Pacific Cell Banking Outsourcing Market Outlook
- 9.1. Market Size & Forecast
- 9.2. Market Share & Forecast
- 9.2.1. By Type
- 9.2.2. By Cell Type
- 9.2.3. By Phase
- 9.2.4. By Country
- 9.3. Asia-Pacific: Country Analysis
- 9.3.1. China Cell Banking Outsourcing Market Outlook
- 9.3.1.1. Market Size & Forecast
- 9.3.1.2. Market Share & Forecast
- 9.3.1.2.1. By Type
- 9.3.1.2.2. By Cell Type
- 9.3.1.2.3. By Phase
- 9.3.2. India Cell Banking Outsourcing Market Outlook
- 9.3.2.1. Market Size & Forecast
- 9.3.2.2. Market Share & Forecast
- 9.3.2.2.1. By Type
- 9.3.2.2.2. By Cell Type
- 9.3.2.2.3. By Phase
- 9.3.3. Japan Cell Banking Outsourcing Market Outlook
- 9.3.3.1. Market Size & Forecast
- 9.3.3.2. Market Share & Forecast
- 9.3.3.2.1. By Type
- 9.3.3.2.2. By Cell Type
- 9.3.3.2.3. By Phase
- 9.3.4. South Korea Cell Banking Outsourcing Market Outlook
- 9.3.4.1. Market Size & Forecast
- 9.3.4.2. Market Share & Forecast
- 9.3.4.2.1. By Type
- 9.3.4.2.2. By Cell Type
- 9.3.4.2.3. By Phase
- 9.3.5. Australia Cell Banking Outsourcing Market Outlook
- 9.3.5.1. Market Size & Forecast
- 9.3.5.2. Market Share & Forecast
- 9.3.5.2.1. By Type
- 9.3.5.2.2. By Cell Type
- 9.3.5.2.3. By Phase
10. South America Cell Banking Outsourcing Market Outlook
- 10.1. Market Size & Forecast
- 10.2. Market Share & Forecast
- 10.2.1. By Type
- 10.2.2. By Cell Type
- 10.2.3. By Phase
- 10.2.4. By Country
- 10.3. South America: Country Analysis
- 10.3.1. Brazil Cell Banking Outsourcing Market Outlook
- 10.3.1.1. Market Size & Forecast
- 10.3.1.2. Market Share & Forecast
- 10.3.1.2.1. By Type
- 10.3.1.2.2. By Cell Type
- 10.3.1.2.3. By Phase
- 10.3.2. Argentina Cell Banking Outsourcing Market Outlook
- 10.3.2.1. Market Size & Forecast
- 10.3.2.2. Market Share & Forecast
- 10.3.2.2.1. By Type
- 10.3.2.2.2. By Cell Type
- 10.3.2.2.3. By Phase
- 10.3.3. Colombia Cell Banking Outsourcing Market Outlook
- 10.3.3.1. Market Size & Forecast
- 10.3.3.2. Market Share & Forecast
- 10.3.3.2.1. By Type
- 10.3.3.2.2. By Cell Type
- 10.3.3.2.3. By Phase
11. Middle East and Africa Cell Banking Outsourcing Market Outlook
- 11.1. Market Size & Forecast
- 11.2. Market Share & Forecast
- 11.2.1. By Type
- 11.2.2. By Cell Type
- 11.2.3. By Phase
- 11.2.4. By Country
- 11.3. MEA: Country Analysis
- 11.3.1. South Africa Cell Banking Outsourcing Market Outlook
- 11.3.1.1. Market Size & Forecast
- 11.3.1.2. Market Share & Forecast
- 11.3.1.2.1. By Type
- 11.3.1.2.2. By Cell Type
- 11.3.1.2.3. By Phase
- 11.3.2. Saudi Arabia Cell Banking Outsourcing Market Outlook
- 11.3.2.1. Market Size & Forecast
- 11.3.2.2. Market Share & Forecast
- 11.3.2.2.1. By Type
- 11.3.2.2.2. By Cell Type
- 11.3.2.2.3. By Phase
- 11.3.3. UAE Cell Banking Outsourcing Market Outlook
- 11.3.3.1. Market Size & Forecast
- 11.3.3.2. Market Share & Forecast
- 11.3.3.2.1. By Type
- 11.3.3.2.2. By Cell Type
- 11.3.3.2.3. By Phase
- 11.3.4. Turkey Cell Banking Outsourcing Market Outlook
- 11.3.4.1. Market Size & Forecast
- 11.3.4.2. Market Share & Forecast
- 11.3.4.2.1. By Type
- 11.3.4.2.2. By Cell Type
- 11.3.4.2.3. By Phase
- 11.3.5. Egypt Cell Banking Outsourcing Market Outlook
- 11.3.5.1. Market Size & Forecast
- 11.3.5.2. Market Share & Forecast
- 11.3.5.2.1. By Type
- 11.3.5.2.2. By Cell Type
- 11.3.5.2.3. By Phase
12. Market Dynamics
- 12.1. Drivers
- 12.2. Challenges
13. Market Trends & Developments
14. Competitive Landscape
- 14.1. Cryo-Cell International, Inc
- 14.2. Charles River Laboratories International, Inc.
- 14.3. Goodwin Biotechnology Inc.
- 14.4. Lonza Group AG
- 14.5. SGS Life Sciences (SGS SA)
- 14.6. Global Stem Inc.
- 14.7. BSL Bioservice Scientific Laboratories GmbH
- 14.8. BioReliance Corporation
15. Strategic Recommendations
